Kazuhiro Asada

1.8k total citations
73 papers, 1.1k citations indexed

About

Kazuhiro Asada is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Kazuhiro Asada has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 26 papers in Physiology and 17 papers in Oncology. Recurrent topics in Kazuhiro Asada's work include Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory and Cough-Related Research (13 papers). Kazuhiro Asada is often cited by papers focused on Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers) and Respiratory and Cough-Related Research (13 papers). Kazuhiro Asada collaborates with scholars based in Japan, United States and China. Kazuhiro Asada's co-authors include Takafumi Suda, Kingo Chida, Toshihiro Shirai, Hirotoshi Nakamura, Satoru Morita, Takefumi Akita, Masato Fujii, Masashi Mikamo, Shigekazu Sasaki and Yuichiro Shishido and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kazuhiro Asada

70 papers receiving 1.1k citations

Peers

Kazuhiro Asada
Kazuhiro Asada
Citations per year, relative to Kazuhiro Asada Kazuhiro Asada (= 1×) peers Hideki Yasui

Countries citing papers authored by Kazuhiro Asada

Since Specialization
Citations

This map shows the geographic impact of Kazuhiro Asada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Asada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Asada more than expected).

Fields of papers citing papers by Kazuhiro Asada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Asada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Asada. The network helps show where Kazuhiro Asada may publish in the future.

Co-authorship network of co-authors of Kazuhiro Asada

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Asada. A scholar is included among the top collaborators of Kazuhiro Asada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Asada. Kazuhiro Asada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Yusuke, Naoki Inui, Masato Karayama, et al.. (2023). Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy. Cancer Immunology Immunotherapy. 72(8). 2717–2728. 6 indexed citations
2.
Oya, Yuko, Tatsuya Yoshida, Kazuhiro Asada, et al.. (2021). Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib. BMC Cancer. 21(1). 57–57. 3 indexed citations
3.
Asada, Kazuhiro, et al.. (2020). Eosinophilic airway inflammation and eosinophilic chronic rhinosinusitis during nivolumab and ipilimumab. Respirology Case Reports. 8(7). e00638–e00638. 10 indexed citations
4.
Shirai, Toshihiro, et al.. (2020). Subacute invasive pulmonary aspergillosis after chemoradiotherapy for lung cancer. Respirology Case Reports. 8(2). e00523–e00523. 4 indexed citations
5.
Karayama, Masato, Naoki Inui, Hideki Yasui, et al.. (2020). Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Investigational New Drugs. 39(1). 210–216. 6 indexed citations
6.
Uchino, Tomonobu, Tomonori Suzuki, Yasunori Miyazaki, et al.. (2020). Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration. Cancer Chemotherapy and Pharmacology. 86(2). 233–243. 5 indexed citations
7.
Tanaka, Yuko, et al.. (2019). Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study. Respiratory Medicine Case Reports. 28. 100885–100885. 8 indexed citations
8.
Suzuki, Takahito, Toshihiro Shirai, Keita Hirai, et al.. (2019). Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis. Respiratory Investigation. 57(3). 252–259. 7 indexed citations
9.
Suzuki, Yuzo, Naoki Inui, Masato Karayama, et al.. (2019). <p>Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD</p>. International Journal of COPD. Volume 14. 1867–1877. 13 indexed citations
10.
Suzuki, Yuzo, Masahiro Shirai, Kazuhiro Asada, et al.. (2018). Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis. Scientific Reports. 8(1). 13129–13129. 47 indexed citations
11.
Matsuura, Shun, et al.. (2018). Surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung. World Journal of Surgical Oncology. 16(1). 33–33. 4 indexed citations
12.
Akamatsu, Taisuke, Toshihiro Shirai, Takahito Suzuki, et al.. (2016). Forced oscillation technique as a predictor of FEV1 improvement in asthma. Respiratory Physiology & Neurobiology. 236. 78–83. 8 indexed citations
13.
Suzuki, Yuzo, Masahiro Shirai, Kazuhiro Asada, et al.. (2016). Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis. Annals of the American Thoracic Society. 14(1). 57–64. 17 indexed citations
14.
Akita, Takefumi, Toshihiro Shirai, Kazutaka Mori, et al.. (2015). Association of the forced oscillation technique with negative expiratory pressure in COPD. Respiratory Physiology & Neurobiology. 220. 62–68. 8 indexed citations
15.
Mikamo, Masashi, Toshihiro Shirai, Kazutaka Mori, et al.. (2013). Predictors of phase III slope of nitrogen single-breath washout in COPD. Respiratory Physiology & Neurobiology. 189(1). 42–46. 25 indexed citations
16.
Suzuki, Yuzo, Takafumi Suda, Kazuhiro Asada, et al.. (2012). Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis. Clinical and Vaccine Immunology. 19(3). 436–442. 86 indexed citations
17.
Asada, Kazuhiro, Shigekazu Sasaki, Takafumi Suda, Kingo Chida, & Hirotoshi Nakamura. (2003). Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages. American Journal of Respiratory and Critical Care Medicine. 169(2). 195–200. 135 indexed citations
18.
Matsuda, Hiroyuki, Takafumi Suda, Hideo Hashizume, et al.. (2002). Alteration of Balance between Myeloid Dendritic Cells and Plasmacytoid Dendritic Cells in Peripheral Blood of Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 166(8). 1050–1054. 78 indexed citations
19.
Suda, Takafumi, Kingo Chida, Kyotaro Ide, et al.. (2002). ONCOSTATIN M PRODUCTION BY HUMAN DENDRITIC CELLS IN RESPONSE TO BACTERIAL PRODUCTS. Cytokine. 17(6). 335–340. 67 indexed citations
20.
Chida, Kingo, Takafumi Suda, Shiro Imokawa, et al.. (2000). Increased Numbers of Dendritic Cells in the Bronchiolar Tissues of Diffuse Panbronchiolitis. American Journal of Respiratory and Critical Care Medicine. 162(1). 148–153. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026